Impaired alveolarization and intra-uterine growth restriction in rats: a postnatal genome-wide analysis

E Zana-Taieb1, H Pham, M L Franco-Montoya

  • 1Université Paris Descartes, Paris, France; Fondation PremUp, 53 avenue de l'Observatoire, 75014 Paris, France; Institut National de la Santé et de la Recherche Médicale (INSERM) U1141, Paris, France; Assistance Publique - Hôpitaux de Paris, Service de Médecine et Réanimation Néonatales de Port-Royal, Groupe Hospitalier Cochin, Broca, Hôtel-Dieu, 53 Avenue de l'Observatoire, 75014 Paris, France.

The Journal of Pathology
|October 29, 2014
PubMed

Insights

Intra-uterine growth restriction (IUGR) impairs lung development in preterm infants. This study reveals that deregulation of the peroxisome proliferator-activated receptor (PPAR) pathway is a key mechanism contributing to impaired alveolarization in IUGR models.

Area of Science:

  • Pulmonary Medicine
  • Developmental Biology
  • Genomics

Background:

  • Intra-uterine growth restriction (IUGR) significantly elevates the risk of bronchopulmonary dysplasia in preterm infants, characterized by arrested alveolarization and abnormal angiogenesis.
  • Previous rodent models of IUGR using a low protein diet (LPD) demonstrated impaired alveolarization but did not identify modifications in classical lung development factors.

Purpose of the Study:

  • To investigate genome-wide transcriptomic changes in a rodent model of LPD-induced IUGR during key stages of lung alveolarization.
  • To identify molecular pathways involved in impaired alveolarization associated with IUGR.

Main Methods:

  • Genome-wide microarray analysis was performed on 120 rat pups with LPD-induced IUGR and controls at postnatal days 4, 10, and 21.
  • Data analysis utilized Arraymining, DAVID, and KEGG software, with validation through qRT-PCR and Western blots.
  • Functional classification identified significantly altered pathways, focusing on cell adhesion molecules, cardiac muscle contraction, and PPAR signaling.

Main Results:

  • Significant numbers of transcripts were up- and down-regulated at all three time points, with the largest changes observed at P21.
  • Functional analysis highlighted the peroxisome proliferator-activated receptor (PPAR) pathway as notably affected.
  • Protein analysis confirmed PPAR pathway involvement, showing increased FABP4 (an activator) at P4 and increased adiponectin at P21.

Conclusions:

  • Deregulation of the PPAR pathway is implicated as a significant factor in the impaired alveolarization observed in IUGR.
  • These findings provide novel insights into the molecular mechanisms underlying IUGR-associated lung developmental defects.
  • The study's comprehensive dataset is publicly available on the Gene Expression Omnibus (GEO) database (GEO Accession No. GSE56956).